Items tagged with Diagnostics
FDA approves fourth generation latent TB blood test (post)
NEW YORK, June 8, 2017 – Qiagen said today that its QuantiFeron-TB Gold Plus (QFT-Plus) blood test for detecting latent tuberculosis infection has received US Food and Drug Administration approval.
An evaluation of automated chest radiography reading software for TB screening among public- and private-sector patients (post)
Abstract
TB testing market worth US$ 2600 million globally by 2021 (post)
The TB testing market is projected to be worth US$ 2600 million globally by 2021.
Comparison of sputum collection methods for TB diagnosis: a systematic review and pairwise and network meta-analysis (post)
Summary
Cost-effectiveness of Xpert MTB/RIF for TB diagnosis in South Africa: a real-world cost analysis and economic evaluation (post)
Summary
France to reimburse IGRAs to screen at-risk individuals for latent TB (post)
The French decision to reimburse interferon-gamma release assays (IGRAs) for TB screening includes QuantiFERON-TB® Gold Plus (QFT-Plus®) and T-SPOT®.TB Test.
Tanzania: Accurate test for TB in children on its way (post)
The detection of childhood tuberculosis (TB) has been a challenge in Tanzania, but research experts are now in a surge to come up with a better, rapid test for many children with TB to be identified and treated.
The impact of glycemic status on radiological manifestations of pulmonary TB in diabetic patients (post)
Abstract
India: Drug-resistant TB higher among children than expected (post)
While detection of tuberculosis (TB) in children remains a challenge, it has now emerged that multidrug-resistant TB (MDR-TB) is higher among children than expected. This has been described as a “worrying trend” by the Union Health Ministry.
Page 23 of 70 · Total posts: 0
←First 22 23 24 Last→